Immune checkpoint inhibitor-induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system.

HOME
>
論文・技術情報
>
Immune checkpoint inhibitor-induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system.

アブストラクト
ジャーナル名	Haemophilia : the official journal of the World Federation of Hemophilia
Pubmed追加日	2022/7/28
投稿者	Moore, Donald C; Elmes, Joseph B; Arnall, Justin R; Strassels, Scott A; Patel, Jai N
組織名	Atrium Health, Department of Pharmacy, Levine Cancer Institute, Charlotte, North;Carolina, USA.;Atrium Health, Department of Pharmacy, Levine Cancer Institute, Concord, North;Atrium Health, Specialty Pharmacy Service, Charlotte, North Carolina, USA.;Department of Pharmacy, Atrium Health, Charlotte, North Carolina, USA.;Atrium Health, Department of Cancer Pharmacology and Pharmacogenomics, Levine;Cancer Institute, Charlotte, North Carolina, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/35895993/